BioMarin to Host Third Quarter 2024 Financial Results Conference Call and Webcast on Tuesday, October 29, 2024, at 4:30pm ET
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced that its President and CEO, Alexander Hardy, will host a conference call and webcast on Tuesday, October 29, 2024, at 4:30 p.m. ET to discuss the company's third quarter 2024 financial results and provide a general business update. The event will be accessible via phone and webcast, with dial-in numbers provided for both U.S./Canada and international participants. A replay of the call will be available, and interested parties can access a live audio webcast through the investor section of BioMarin's website. The replay will be archived on the site for one week following the call.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha annunciato che il suo Presidente e CEO, Alexander Hardy, ospiterà una conferenza telefonica e un webcast martedì 29 ottobre 2024, alle 16:30 ET per discutere i risultati finanziari del terzo trimestre 2024 e fornire un aggiornamento generale sull'azienda. L'evento sarà accessibile via telefono e webcast, con numeri di accesso forniti per i partecipanti degli Stati Uniti/Canada e internazionali. Una registrazione della chiamata sarà disponibile, e le parti interessate possono accedere a un webcast audio dal vivo tramite la sezione investitori del sito web di BioMarin. La registrazione sarà archiviata sul sito per una settimana dopo la chiamata.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha anunciado que su Presidente y CEO, Alexander Hardy, llevará a cabo una conferencia telefónica y webcast el martes 29 de octubre de 2024, a las 4:30 p.m. ET para discutir los resultados financieros del tercer trimestre de 2024 y ofrecer una actualización general de la empresa. El evento será accesible por teléfono y webcast, con números de acceso proporcionados para participantes de EE. UU./Canadá e internacionales. Se dispondrá de una grabación de la llamada y las partes interesadas pueden acceder a un webcast de audio en vivo a través de la sección para inversores del sitio web de BioMarin. La grabación se archivará en el sitio durante una semana después de la llamada.
바이오마린 제약 주식회사(BioMarin Pharmaceutical Inc., NASDAQ: BMRN)는 CEO이자 사장인 알렉산더 하디(Alexander Hardy)가 2024년 10월 29일 화요일 오후 4시 30분 ET에 회사의 2024년 3분기 재무 결과에 대해 논의하고 일반 사업 업데이트를 제공하기 위한 전화 회의 및 웹캐스트를 진행한다고 발표했습니다. 이 이벤트는 전화와 웹캐스트를 통해 접근 가능하며 미국/캐나다 및 국제 참가자를 위한 다이얼인 번호가 제공됩니다. 회의 녹음이 제공되며, 관심 있는 당사자는 바이오마린 웹사이트의 투자자 섹션을 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다. 회의 녹음은 호출 후 일주일 동안 사이트에 보관됩니다.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) a annoncé que son président et CEO, Alexander Hardy, organisera un appel de conférence et un webinaire le mardi 29 octobre 2024, à 16h30 ET pour discuter des résultats financiers du troisième trimestre 2024 et fournir une mise à jour générale sur l'entreprise. L'événement sera accessible par téléphone et par webinaire, avec des numéros de connexion fournis pour les participants des États-Unis/Canada et internationaux. Un enregistrement de l'appel sera disponible, et les parties intéressées peuvent accéder à un webinaire audio en direct via la section des investisseurs du site web de BioMarin. L'enregistrement sera archivé sur le site pendant une semaine après l'appel.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hat angekündigt, dass sein Präsident und CEO, Alexander Hardy, am Dienstag, den 29. Oktober 2024, um 16:30 Uhr ET einen Konferenzanruf und ein Webcast veranstalten wird, um die finanziellen Ergebnisse des dritten Quartals 2024 zu erörtern und eine allgemeine Unternehmensaktualisierung zu geben. Die Veranstaltung wird sowohl telefonisch als auch im Webcast zugänglich sein, wobei Einwahlnummern für US-/Kanada-Teilnehmer sowie internationale Teilnehmer bereitgestellt werden. Eine Wiederholung des Anrufs wird verfügbar sein, und interessierte Parteien können über den Investorenbereich der BioMarin-Website auf einen Live-Audio-Webcast zugreifen. Die Wiederholung wird eine Woche lang auf der Website archiviert.
- None.
- None.
Dial-in Number
International Dial-in Number: 646-968-2525
Conference Call ID: 4980126
International Replay Dial-in Number: 609-800-9909
Playback ID: 4980126
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2024-financial-results-conference-call-and-webcast-on-tuesday-october-29-2024-at-430pm-et-302277174.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When will BioMarin (BMRN) release its Q3 2024 financial results?
How can investors access BioMarin's (BMRN) Q3 2024 earnings call?
Who will host BioMarin's (BMRN) Q3 2024 earnings call?
Will there be a replay available for BioMarin's (BMRN) Q3 2024 earnings call?
